Plant Advanced Technologies Past Earnings Performance
Past criteria checks 0/6
Plant Advanced Technologies has been growing earnings at an average annual rate of 25.1%, while the Biotechs industry saw earnings growing at 17.7% annually. Revenues have been growing at an average rate of 1.5% per year.
Key information
25.1%
Earnings growth rate
25.7%
EPS growth rate
| Biotechs Industry Growth | 30.8% |
| Revenue growth rate | 1.5% |
| Return on equity | -12.4% |
| Net Margin | -36.3% |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Plant Advanced Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 2 | -1 | 4 | 0 |
| 30 Sep 22 | 1 | -1 | 4 | 0 |
| 30 Jun 22 | 5 | -1 | 4 | 0 |
| 31 Mar 22 | 4 | -1 | 3 | 0 |
| 31 Dec 21 | 2 | -1 | 3 | 0 |
| 30 Sep 21 | 5 | -1 | 4 | 0 |
| 30 Jun 21 | 3 | -1 | 2 | 0 |
| 31 Mar 21 | 2 | -1 | 2 | 0 |
| 31 Dec 20 | 3 | -1 | 3 | 0 |
| 30 Sep 20 | 2 | -1 | 2 | 0 |
| 30 Jun 20 | 2 | -1 | 2 | 0 |
| 31 Mar 20 | 2 | -1 | 2 | 0 |
| 31 Dec 19 | 2 | -1 | 2 | 0 |
| 30 Sep 19 | 2 | 0 | 1 | 0 |
| 30 Jun 19 | 2 | 1 | 2 | 0 |
| 31 Mar 19 | 2 | 1 | 2 | 0 |
| 31 Dec 18 | 2 | 1 | 2 | 0 |
| 30 Sep 18 | 2 | 0 | 2 | 0 |
| 30 Jun 18 | 2 | -1 | 2 | 0 |
| 31 Mar 18 | 2 | -1 | 2 | 0 |
| 31 Dec 17 | 1 | -1 | 2 | 0 |
| 30 Sep 17 | 2 | -1 | 2 | 0 |
| 30 Jun 17 | 2 | 0 | 2 | 0 |
| 31 Mar 17 | 2 | -1 | 2 | 0 |
| 31 Dec 16 | 2 | -1 | 2 | 0 |
| 30 Sep 16 | 2 | -1 | 2 | 0 |
| 30 Jun 16 | 2 | -2 | 2 | 0 |
| 31 Mar 16 | 2 | -1 | 2 | 0 |
| 31 Dec 15 | 2 | -1 | 1 | 0 |
| 30 Sep 15 | 2 | -1 | 1 | 0 |
| 30 Jun 15 | 2 | -1 | 1 | 0 |
| 31 Mar 15 | 2 | -1 | 1 | 0 |
| 31 Dec 14 | 2 | -1 | 1 | 0 |
| 30 Sep 14 | 2 | 0 | 1 | 0 |
| 30 Jun 14 | 2 | 0 | 1 | 0 |
| 31 Mar 14 | 2 | 0 | 1 | 0 |
| 31 Dec 13 | 2 | 0 | 1 | 0 |
Quality Earnings: ALPAT is currently unprofitable.
Growing Profit Margin: ALPAT is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if ALPAT's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare ALPAT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ALPAT is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-11.5%).
Return on Equity
High ROE: ALPAT has a negative Return on Equity (-12.36%), as it is currently unprofitable.